XOStem Company
XOStem a stem cell biotechnology platform that creates treatment for Type 1 diabetes and produces engineered exosomes. The company was founded in 2018 and is headquartered in Irvine, California.
Industry:
Regenerative Medicine
Headquarters:
Irvine, California, United States
Zip:
1-10
Founded Date:
2018-01-01
Employees Number:
1-10
Investors Number:
302651
Total Funding:
302651
Last Funding Date:
Seed
Last Funding Type:
info@xostem.com
Register and Claim Ownership